FY18 ARP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov. 

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

http://cdmrp.army.mil/funding/arp

Clinical Trial Award – Preapplication due July 5, 2018

• Investigators at or above the level of Associate Professor (or equivalent), or
• Early-Career Investigator Partnering PI Option: Investigators at or above the level of Associate Professor (or equivalent) may collaborate on a single application with a young investigator (at the level of postdoctoral fellow up to early-career independent faculty) who meets the following criteria at the application submission deadline date:
• Must be in a current postdoctoral training position or have completed postdoctoral training by the  application deadline
• Is no more than 7 years from the receipt of a terminal degree
• Has the freedom to commit at least 50% time to the project
• Supports research with the potential to have a major impact on the treatment and/or management of ASD.
• Applications in the following areas are strongly encouraged:
• • Behavioral cognitive, and other non-pharmacological therapies.
  • Pharmacological, genetic, and other biological treatments in ASD.
  • Dissemination/Implementation of clinically validated interventions.
  • Therapies to alleviate conditions co-occurring with ASD (i.e., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures).
  • Interventions promoting success in key transitions to adulthood for individuals living with ASD.
  • Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the lifespan and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief).
  • Improve diagnosis across the lifespan.
  • Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services.
• Preliminary data relevant to the proposed clinical trial are required.
• Pre-application is required; application submission is by invitation only.
• Early-Career Investigator Partnering PI Option: Supports the development of young investigators pursuing or wishing to clinical trial.
• The maximum allowable funding for the entire period of performance is $1,000,000 in direct costs (plus indirect costs)
• The maximum period of performance is 4 years
• Early-Career Investigator Partnering PI Option:
• Maximum funding of $1,155,000 in direct costs (plus indirect costs)
• Maximum period of performance is 4 years

Clinical Translational Award – Preapplication is due July 5, 2018

• Investigators at or above the level of Assistant Professor (or equivalent)
• Supports early-phase, proof-of-principle translational studies with the potential to have a major impact on the treatment and/or management of autism spectrum disorder (ASD).
• Applications in the following areas are strongly encouraged:
• • Behavioral cognitive, and other non-pharmacological therapies.
  • Pharmacological, genetic, and other biological treatments in ASD.
  • Dissemination/Implementation of clinically validated interventions.
  • Therapies to alleviate conditions co-occurring with ASD (i.e., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures).
  • Interventions promoting success in key transitions to adulthood for individuals living with ASD.
  • Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the lifespan and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief).
  • Improve diagnosis across the lifespan.
  • Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services.
• Preliminary data relevant to the proposed project are required.
• Pre-application is required; application submission is by invitation only.
• The maximum allowable funding for the entire period of performance is $500,000 in direct costs (plus indirect costs)
• The maximum period of performance is 3 years

Idea Development Award – Preapplication is due July 5, 2018

• Investigators at or above the level of Assistant Professor (or equivalent) or
• Multiple PI Option: 
  Up to two investigators may collaborate on a single application, each of whom will be recognized as a Principal Investigator and receive a separate award. 
• Supports the development of innovative, high-impact ideas that advance the understanding of ASD and ultimately lead to improved outcomes.
• Applications in the following areas are strongly encouraged:

• Preliminary data are required.
• Pre-application is required; application submission is by invitation only.
• Multiple Principal Investigator (PI) Option: Up to two investigators may collaborate on a single application, each of whom will be recognized as a PI and receive a separate award.
• The maximum allowable funding for the entire period of performance is $500,000 in direct costs (plus indirect costs)
• For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $500,000 in direct costs (plus indirect costs)
• The maximum period of performance is 3 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the ARP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507
help@eBrap.org